BioTwin gives clinicians novel longitudinal information about their patients' biology, behavior, and history to support earlier conversations and better-targeted decisions.
Clinical availability: UAE only, through participating physicians in authorized settings. BioTwin is not authorized as a medical device in Canada or the United States. Do not use BioTwin clinical outputs for patient care in jurisdictions where authorization has not been granted.
What BioTwin is, and what it is not
A virtual twin does not replace a clinician. A virtual twin is there to assist clinicians in making better-informed decisions. BioTwin is not and never will be an expert in oncology, neurology, or cardiology. BioTwin's role is to provide the data infrastructure that lets the experts do their best work, by giving them novel longitudinal information they do not otherwise have access to.
Clinical availability by region
UAEUAE only: available through participating physicians in authorized clinical settings for screening decision assistance across six cancers, with breast and colorectal cancer as the priority.
CanadaCanada: BioTwin is not authorized as a medical device. Not available for clinical screening decision assistance.
United StatesUnited States: BioTwin is not authorized as a medical device. Not available for clinical screening decision assistance.
Health condition roadmap
Roadmap items describe regulated clinical development priorities, not current commercial availability outside authorized settings.
BioTwin is building its clinical roadmap in stages, with oncology first, neurology second, and cardiology third.
Top priority
Oncology
Breast cancer
Colorectal cancer
Lung cancer
Pancreatic cancer
Prostate cancer
Ovarian cancer
Second priority
Neurology
Parkinson's disease
Alzheimer's disease
Epilepsy
Major depressive disorder
Third priority
Cardiology
Hypertension
Heart failure
The clinical role of the virtual twin
Earlier and better-targeted screening conversations
Longitudinal monitoring across repeated samples
A discussion-ready summary for the clinician's decision-making
